Global Short Sleep Syndrome Treatment market size is predicted to grow from US$ 10840 million in 2025 to US$ 18510 million in 2031; it is expected to grow at a CAGR of 9.3% from 2025 to 2031.

Global Short Sleep Syndrome Treatment Market Size, Share and Analysis

The global Short Sleep Syndrome Treatment market size is predicted to grow from US$ 10840 million in 2025 to US$ 18510 million in 2031; it is expected to grow at a CAGR of 9.3% from 2025 to 2031. Short Sleep Syndrome is a sleep condition characterized by sleeping for fewer than six hours each night . Most adults need seven or more hours of sleep each night to feel rested in the morning. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Short Sleep Syndrome Treatment Industry Forecast looks at past sales and reviews total world Short Sleep Syndrome Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Short Sleep Syndrome Treatment sales for 2025 through 2031. With Short Sleep Syndrome Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Short Sleep Syndrome Treatment industry. This Insight Report provides a comprehensive analysis of the global Short Sleep Syndrome Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Short Sleep Syndrome Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Short Sleep Syndrome Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Short Sleep Syndrome Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Short Sleep Syndrome Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Short Sleep Syndrome Treatment market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Benzodiazepines &nbsp;&nbsp;&nbsp; Nonbenzodiazepines &nbsp;&nbsp;&nbsp; Antidepressants &nbsp;&nbsp;&nbsp; Orexin Antagonist &nbsp;&nbsp;&nbsp; Melatonin Antagonist &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital Pharmacies &nbsp;&nbsp;&nbsp; Retail Pharmacies &nbsp;&nbsp;&nbsp; Online Pharmacies This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck & co. &nbsp;&nbsp;&nbsp; Mylan N.V. &nbsp;&nbsp;&nbsp; Paratek pharmaceuticals &nbsp;&nbsp;&nbsp; Pfizer Inc. &nbsp;&nbsp;&nbsp; Sanofi S.A. &nbsp;&nbsp;&nbsp; Sumitomo Dainippon pharma Co. Ltd. &nbsp;&nbsp;&nbsp; Takeda Pharmaceuticals Company Ltd. &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd. &nbsp;&nbsp;&nbsp; Vanda Pharmaceuticals Inc. Key Questions Addressed in this Report What is the 10-year outlook for the global Short Sleep Syndrome Treatment market? What factors are driving Short Sleep Syndrome Treatment market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Short Sleep Syndrome Treatment market opportunities vary by end market size? How does Short Sleep Syndrome Treatment break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Short Sleep Syndrome Treatment Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Short Sleep Syndrome Treatment by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Short Sleep Syndrome Treatment by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Short Sleep Syndrome Treatment Segment by Type &nbsp;2.2.1 Benzodiazepines &nbsp;2.2.2 Nonbenzodiazepines &nbsp;2.2.3 Antidepressants &nbsp;2.2.4 Orexin Antagonist &nbsp;2.2.5 Melatonin Antagonist &nbsp;2.2.6 Other &nbsp;2.3 Short Sleep Syndrome Treatment Sales by Type &nbsp;2.3.1 Global Short Sleep Syndrome Treatment Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Short Sleep Syndrome Treatment Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Short Sleep Syndrome Treatment Sale Price by Type (2020-2025) &nbsp;2.4 Short Sleep Syndrome Treatment Segment by Application &nbsp;2.4.1 Hospital Pharmacies &nbsp;2.4.2 Retail Pharmacies &nbsp;2.4.3 Online Pharmacies &nbsp;2.5 Short Sleep Syndrome Treatment Sales by Application &nbsp;2.5.1 Global Short Sleep Syndrome Treatment Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Short Sleep Syndrome Treatment Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Short Sleep Syndrome Treatment Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Short Sleep Syndrome Treatment Breakdown Data by Company &nbsp;3.1.1 Global Short Sleep Syndrome Treatment Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Short Sleep Syndrome Treatment Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Short Sleep Syndrome Treatment Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Short Sleep Syndrome Treatment Revenue by Company (2020-2025) &nbsp;3.2.2 Global Short Sleep Syndrome Treatment Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Short Sleep Syndrome Treatment Sale Price by Company &nbsp;3.4 Key Manufacturers Short Sleep Syndrome Treatment Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Short Sleep Syndrome Treatment Product Location Distribution &nbsp;3.4.2 Players Short Sleep Syndrome Treatment Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Short Sleep Syndrome Treatment by Geographic Region &nbsp;4.1 World Historic Short Sleep Syndrome Treatment Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Short Sleep Syndrome Treatment Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Short Sleep Syndrome Treatment Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Short Sleep Syndrome Treatment Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Short Sleep Syndrome Treatment Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Short Sleep Syndrome Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Short Sleep Syndrome Treatment Sales Growth &nbsp;4.4 APAC Short Sleep Syndrome Treatment Sales Growth &nbsp;4.5 Europe Short Sleep Syndrome Treatment Sales Growth &nbsp;4.6 Middle East & Africa Short Sleep Syndrome Treatment Sales Growth 5 Americas &nbsp;5.1 Americas Short Sleep Syndrome Treatment Sales by Country &nbsp;5.1.1 Americas Short Sleep Syndrome Treatment Sales by Country (2020-2025) &nbsp;5.1.2 Americas Short Sleep Syndrome Treatment Revenue by Country (2020-2025) &nbsp;5.2 Americas Short Sleep Syndrome Treatment Sales by Type (2020-2025) &nbsp;5.3 Americas Short Sleep Syndrome Treatment Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Short Sleep Syndrome Treatment Sales by Region &nbsp;6.1.1 APAC Short Sleep Syndrome Treatment Sales by Region (2020-2025) &nbsp;6.1.2 APAC Short Sleep Syndrome Treatment Revenue by Region (2020-2025) &nbsp;6.2 APAC Short Sleep Syndrome Treatment Sales by Type (2020-2025) &nbsp;6.3 APAC Short Sleep Syndrome Treatment Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Short Sleep Syndrome Treatment by Country &nbsp;7.1.1 Europe Short Sleep Syndrome Treatment Sales by Country (2020-2025) &nbsp;7.1.2 Europe Short Sleep Syndrome Treatment Revenue by Country (2020-2025) &nbsp;7.2 Europe Short Sleep Syndrome Treatment Sales by Type (2020-2025) &nbsp;7.3 Europe Short Sleep Syndrome Treatment Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Short Sleep Syndrome Treatment by Country &nbsp;8.1.1 Middle East & Africa Short Sleep Syndrome Treatment Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Short Sleep Syndrome Treatment Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Short Sleep Syndrome Treatment Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Short Sleep Syndrome Treatment Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Short Sleep Syndrome Treatment &nbsp;10.3 Manufacturing Process Analysis of Short Sleep Syndrome Treatment &nbsp;10.4 Industry Chain Structure of Short Sleep Syndrome Treatment 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Short Sleep Syndrome Treatment Distributors &nbsp;11.3 Short Sleep Syndrome Treatment Customer 12 World Forecast Review for Short Sleep Syndrome Treatment by Geographic Region &nbsp;12.1 Global Short Sleep Syndrome Treatment Market Size Forecast by Region &nbsp;12.1.1 Global Short Sleep Syndrome Treatment Forecast by Region (2026-2031) &nbsp;12.1.2 Global Short Sleep Syndrome Treatment Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Short Sleep Syndrome Treatment Forecast by Type (2026-2031) &nbsp;12.7 Global Short Sleep Syndrome Treatment Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck & co. &nbsp;13.1.1 Merck & co. Company Information &nbsp;13.1.2 Merck & co. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.1.3 Merck & co. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck & co. Main Business Overview &nbsp;13.1.5 Merck & co. Latest Developments &nbsp;13.2 Mylan N.V. &nbsp;13.2.1 Mylan N.V. Company Information &nbsp;13.2.2 Mylan N.V. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.2.3 Mylan N.V. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Mylan N.V. Main Business Overview &nbsp;13.2.5 Mylan N.V. Latest Developments &nbsp;13.3 Paratek pharmaceuticals &nbsp;13.3.1 Paratek pharmaceuticals Company Information &nbsp;13.3.2 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Paratek pharmaceuticals Main Business Overview &nbsp;13.3.5 Paratek pharmaceuticals Latest Developments &nbsp;13.4 Pfizer Inc. &nbsp;13.4.1 Pfizer Inc. Company Information &nbsp;13.4.2 Pfizer Inc. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Pfizer Inc. Main Business Overview &nbsp;13.4.5 Pfizer Inc. Latest Developments &nbsp;13.5 Sanofi S.A. &nbsp;13.5.1 Sanofi S.A. Company Information &nbsp;13.5.2 Sanofi S.A. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sanofi S.A. Main Business Overview &nbsp;13.5.5 Sanofi S.A. Latest Developments &nbsp;13.6 Sumitomo Dainippon pharma Co. Ltd. &nbsp;13.6.1 Sumitomo Dainippon pharma Co. Ltd. Company Information &nbsp;13.6.2 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Sumitomo Dainippon pharma Co. Ltd. Main Business Overview &nbsp;13.6.5 Sumitomo Dainippon pharma Co. Ltd. Latest Developments &nbsp;13.7 Takeda Pharmaceuticals Company Ltd. &nbsp;13.7.1 Takeda Pharmaceuticals Company Ltd. Company Information &nbsp;13.7.2 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.7.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Takeda Pharmaceuticals Company Ltd. Main Business Overview &nbsp;13.7.5 Takeda Pharmaceuticals Company Ltd. Latest Developments &nbsp;13.8 Teva Pharmaceutical Industries Ltd. &nbsp;13.8.1 Teva Pharmaceutical Industries Ltd. Company Information &nbsp;13.8.2 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Teva Pharmaceutical Industries Ltd. Main Business Overview &nbsp;13.8.5 Teva Pharmaceutical Industries Ltd. Latest Developments &nbsp;13.9 Vanda Pharmaceuticals Inc. &nbsp;13.9.1 Vanda Pharmaceuticals Inc. Company Information &nbsp;13.9.2 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Portfolios and Specifications &nbsp;13.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Vanda Pharmaceuticals Inc. Main Business Overview &nbsp;13.9.5 Vanda Pharmaceuticals Inc. Latest Developments 14 Research Findings and Conclusion

Report	Global Short Sleep Syndrome Treatment Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50442

Buyer Information

Order Summary